Responses of skeletal muscle lipid metabolism in rat gastrocnemius to hypothyroidism and iodothyronine administration: A putative role for FAT/CD36

American Journal of Physiology - Endocrinology and Metabolism

Volumn 303, Issue 10, 2012, Pages

  Lombardi, Assunta ^a   De Matteis, Rita ^b   Moreno, Maria ^c   Napolitano, Laura ^a   Busiello, Rosa Anna ^a   Senese, Rosalba ^d   de Lange, Pieter ^d   Lanni, Antonia ^d   Goglia, Fernando ^c  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b UNIVERSITY OF URBINO   (Italy)

^c UNIVERSITY OF SANNIO   (Italy)

^d SECOND UNIVERSITY OF NAPLES   (Italy)

Author keywords

3,5 diiodo L thyronine; Fatty acid translocase; Lipid handling; Thyroid hormones

Indexed keywords

CARNITINE PALMITOYLTRANSFERASE; CD36 ANTIGEN; FAT; FATTY ACID; GLYCEROL; IODOTHYRONINE; LIOTHYRONINE; THYROID HORMONE; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELLULAR DISTRIBUTION; ENZYME ACTIVITY; FATTY ACID BLOOD LEVEL; FATTY ACID OXIDATION; GASTROCNEMIUS MUSCLE; HYPOTHYROIDISM; IMMUNOHISTOCHEMISTRY; LIPID METABOLISM; LIPOLYSIS; MALE; METABOLIC PARAMETERS; MITOCHONDRION; NONHUMAN; OXIDATIVE PHOSPHORYLATION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RAT; SARCOLEMMA; SKELETAL MUSCLE; THYROID HORMONE BLOOD LEVEL; UPREGULATION;

ANIMALS; ANTIGENS, CD36; BLOTTING, WESTERN; CALORIMETRY, INDIRECT; CELL LINE; DIIODOTHYRONINES; FATTY ACIDS, NONESTERIFIED; HYPOTHYROIDISM; IMMUNOHISTOCHEMISTRY; LIPID METABOLISM; MALE; MICE; MITOCHONDRIA, MUSCLE; MUSCLE, SKELETAL; RATS; RATS, WISTAR; REAL-TIME POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRIIODOTHYRONINE;

EID: 84869180485     PISSN: 01931849     EISSN: 15221555     Source Type: Journal    
DOI: 10.1152/ajpendo.00037.2012     Document Type: Article

References (42)

1. Alexson SE, Nedergaard J. A novel type of short-and medium-chain acyl-CoA hydrolases in brown adipose tissue mitochondria. J Biol Chem 263: 13564-13571, 1988.
2. Baxter JD, Webb P. Thyroid hormone mimetics: potential applications in atherosclerosis, obesity and type 2 diabetes. Nat Rev Drug Discov 8: 308-320, 2009.
3. Bonen A, Luiken JJ, Arumugam Y, Glatz JF, Tandon NN. Acute regulation of fatty acid uptake involves the cellular redistribution of fatty acid translocase. J Biol Chem 275: 14501-14508, 2000.
4. Brenta G, Danzi S, Klein I. Potential therapeutic applications of thyroid hormone analogs. Nat Clin Pract Endocrinol Metab 3: 632-640, 2007.
5. Cable EE, Finn PD, Stebbins JW, Hou J, Ito BR, van Poelje PD, Linemeyer DL, Erion MD. Reduction of hepatic steatosis in rats and mice after treatment with a liver-targeted thyroid hormone receptor agonist. Hepatology 49: 407-417, 2009.
6. Clark AM, Sousa KM, Jennings C, MacDougald OA, Kennedy RT. Continuous-flow enzyme assay on a microfluidic chip for monitoring glycerol secretion from cultured adipocytes. Anal Chem 81: 2350-2356, 2009
7. de Lange P, Cioffi F, Senese R, Moreno M, Lombardi A, Silvestri E, De Matteis R, Lionetti L, Mollica MP, Goglia F, Lanni A. Nonthyrotoxic prevention of diet-induced insulin resistance by 3,5-diiodo-Lthyronine in rats. Diabetes 60: 2730-2739, 2011.
8. de Lange P, Senese R, Cioffi F, Moreno M, Lombardi A, Silvestri E, Goglia F, Lanni A. Rapid activation by 3,5,3′-L-triiodothyronine of adenosine 5′-monophosphate-activated protein kinase/acetyl-coenzyme a carboxylase and akt/protein kinase B signaling pathways: relation to changes in fuel metabolism and myosin heavy-chain protein content in rat gastrocnemius muscle in vivo. Endocrinology 149: 6462-6470, 2008.
9. Enoksson S, Hagström-Toft E, Nordahl J, Hultenby K, Pettersson N, Isaksson B, Permert J, Wibom R, Holm C, Bolinder J, Arner P. Marked reutilization of free fatty acids during activated lipolysis in human skeletal muscle. J Clin Endocrinol Metab 90: 1189-1195, 2005.
10. Flores-Morales A, Gullberg H, Fernandez L, Ståhlberg N, Lee NH, Vennström B, Norstedt G. Patterns of liver gene expression governed by TRbeta. Mol Endocrinol 16: 1257-1268, 2002.
11. Folch J, Lees M, Stanley GH. A simple method for the isolation and purification of total lipids from animal tissues. J Biol Chem 226: 497-510, 1957
12. Glatz JF, Luiken JJ, Bonen A. Membrane fatty acid transporters as regulators of lipid metabolism: implications for metabolic disease. Physiol Rev 90: 307-417, 2010.
13. Goglia F. Biological effects of 3,5-diiodothyronine [T(2)]. Biochemistry (Mosc) 70: 164-172, 2005.
14. Grasselli E, Voci A, Canesi L, Goglia F, Ravera S, Panfoli I, Gallo G, Vergani L. Non-receptor-mediated actions are responsible for the lipidlowering effects of iodothyronines in FaO rat hepatoma cells. J Endocrinol 210: 59-69, 2011.
15. Hartree EF. Determination of protein: a modification of the Lowry method that gives a linear photometric response. Anal Biochem 48: 422-427, 1972.
16. Hoch FL. Lipids and thyroid hormones. Prog Lipid Res 27: 199-270, 1988
17. Holloway GP, Jain SS, Bezaire V, Han XX, Glatz JF, Luiken JJ, Harper ME, Bonen A. FAT/CD36-null mice reveal that mitochondrial FAT/CD36 is required to upregulate mitochondrial fatty acid oxidation in contracting muscle. Am J Physiol Regul Integr Comp Physiol 297: R960-R967, 2009.
18. Holloway GP, Luiken JJ, Glats JF, Spriet LL, Bonen A. Contribution of FAT/CD36 to the regulation of skeletal muscle fatty acid oxidation: an overview. Acta Physiol (Oxf) 194: 293-309, 2008.
19. Izumo S, Nadal-Ginard B, Mahdavi V. All members of the MHC multigene family respond to thyroid hormone in a highly tissue specific manner. Science 231: 597-600, 1986.
20. Jeppesen J, Mogensen M, Prats C, Sahlin K, Madsen K, Kiens B. BFAT/CD36 is localized in sarcolemma and in vesicle-like structures in subsarcolemma regions but not in mitochondria. J Lipid Res 51: 1504-1512, 2010.
21. Keizer HA, Schaart G, Tandon NN, Glatz JF, Luiken JJ. Subcellular immunolocalisation of fatty acid translocase (FAT)/CD36 in human type-1 and type-2 skeletal muscle fibres. Histochem Cell Biol 121: 101-107, 2004
22. King KL, Stanley WC, Rosca M, Kerner J, Hoppel CL, Febbraio M. Fatty acid oxidation in cardiac and skeletal muscle mitochondria is unaffected by deletion of CD36. Arch Biochem Biophys 467: 234-238, 2007
23. Klieverik LT, Coomans CP, Endert E, Sauerwein HP, Havekes LM, Voshol PJ, Rensen CN, Romijn A, Kalsbeek A, Fliers E. Thyroid hormone effect on whole body energy homeostasis and tissue specific fatty acid uptake in vivo. Endocrinology 150: 5639-5648, 2009.
24. Krotkiewski M. Thyroid hormones and treatment of obesity. Int J Obes Relat Metab Disord 24, Suppl 2: S116-S119, 2000.
25. Ladenson PW, Kristensen JD, Ridgway EC, Olsson AG, Carlsson B, Klein I, Baxter JD, Angelin B. Use of the thyroid hormone analogue eprotirome in statin-treated dyslipidemia. N Engl J Med 62: 906-916, 2010
26. Lanni A, Moreno M, Lombardi A, de Lange P, Silvestri E, Ragni M, Farina P, Baccari GC, Fallahi P, Antonelli A, Goglia F. 3,5-diiodo-Lthyronine powerfully reduces adiposity in rats by increasing the burning of fats. FASEB J 19: 1552-1554, 2005.
27. Lombardi A, de Lange P, Silvestri E, Busiello RA, Lanni A, Goglia F, Moreno M. 3,5-Diiodo-L-thyronine rapidly enhances mitochondrial fatty acid oxidation rate and thermogenesis in rat skeletal muscle: AMPactivated protein kinase involvement. Am J Physiol Endocrinol Metab 296: E497-E502, 2009.
28. Lombardi A, Lanni A, de Lange P, Silvestri E, Grasso P, Senese R, Goglia F, Moreno M. Acute administration of 3,5-diiodo-L-thyronine to hypothyroid rats affects bioenergetic parameters in rat skeletal muscle mitochondria. FEBS Lett 581: 5911-5916, 2007.
29. Magnus-Levy A. Ueber den respiratorischen Gaswechselunter Einfluss de Thyroid easo wieunterverschiedenen pathologische Zustand. Berlin Klin-Wochschr 32: 650-652, 1895.
30. Moreno M, de Lange P, Lombardi A, Silvestri E, Lanni A, Goglia F. Metabolic effects of thyroid hormone derivatives. Thyroid 18: 239-253, 2008
31. Moreno M, Lanni A, Lombardi A, Goglia F. How the thyroid controls metabolism in the rat: different roles for triiodothyronine and diiodothyronines. J Physiol 505: 529-538, 1997.
32. Moreno M, Silvestri E, De Matteis R, de Lange P, Lombardi A, Glinni D, Senese R, Cioffi F, Salzano AM, Scaloni A, Lanni A, Goglia F. 3,5-Diiodo-L-thyronine prevents high-fat-diet-induced insulin resistance in rat skeletal muscle through metabolic and structural adaptations. FASEB J 25: 3312-3324, 2011.
33. Oppenheimer JH, Schwartz HL, Lane JT, Thompson MP. Functional relationship of thyroid hormone-induced lipogenesis, lipolysis, and thermogenesis in the rat. J Clin Invest 87: 125-132, 1991.
34. Ribeiro MO. Effects of thyroid hormone analogs on lipid metabolism and thermogenesis. Thyroid 18: 197-203, 2008.
35. Schwenk RW, Holloway GP, Luiken JJ, Bonen A, Glatz JF. Fatty acid transport across the cell membrane: regulation by fatty acid transporters. Prostaglandins Leukot Essent Fatty Acids 82: 149-154, 2010.
36. Silva JE. Thermogenic mechanisms and their hormonal regulation. Physiol Rev 86: 435-464, 2006.
37. Silva E. Fat and energy economy in hypo-and hyperthyroidism are not the mirror image of one another. Endocrinology 51: 4-6, 2010.
38. Silvestri E, Burrone L, de Lange P, Lombardi A, Farina P, Chambery A, Parente A, Lanni A, Goglia F, Moreno M. Thyroid-state influence on protein-expression profile of rat skeletal muscle. J Proteome Res 6: 3187-3196, 2007.
39. Smith BK, Jain SS, Rimbaud S, Dam A, Quadrilatero J, Ventura-Clapier R, Bonen A, Holloway GP. FAT/CD36 is located on the outer mitochondrial membrane, upstream of long-chain acyl-CoA synthetase, and regulates palmitate oxidation. Biochem J 437: 125-134, 2011.
40. Tancevski I, Eller P, Patsch JR, Ritsch A. The resurgence of thyromimetics as lipid-modifying agents. Curr Opin Investig Drugs 10: 912-918, 2009
41. van der Putten HH, Friesema EC, Abumrad NA, Everts ME, Visser TJ. Thyroid hormone transport by the rat fatty acid translocase. Endocrinology 144: 1315-1323, 2003.
42. Yen PM. Physiological and molecular basis of thyroid hormone action. Physiol Rev 81: 1097-1142, 2001.